These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15288088)

  • 41. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of pulmonary arterial hypertension.
    Ricachinevsky CP; Amantéa SL
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S153-65. PubMed ID: 17136291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evidence-based approach to the management of pulmonary arterial hypertension.
    Coyne TC
    Curr Opin Cardiol; 2006 Sep; 21(5):526; author reply 526-7. PubMed ID: 16900019
    [No Abstract]   [Full Text] [Related]  

  • 44. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in pulmonary vascular disease.
    Adatia I
    Curr Opin Pediatr; 2002 Jun; 14(3):292-7. PubMed ID: 12011667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension.
    Sugimura K; Fukumoto Y; Satoh K; Nochioka K; Miura Y; Aoki T; Tatebe S; Miyamichi-Yamamoto S; Shimokawa H
    Circ J; 2012; 76(2):485-8. PubMed ID: 22185711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Primary pulmonary hypertension: prospects for treatment].
    Sáenz de la Calzada C
    Med Clin (Barc); 2004 Jan; 122(2):62-3. PubMed ID: 14733858
    [No Abstract]   [Full Text] [Related]  

  • 48. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
    Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
    Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in the treatment of secondary pulmonary hypertension.
    Maloney JP
    Curr Opin Pulm Med; 2003 Mar; 9(2):139-43. PubMed ID: 12574694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
    Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
    Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review.
    Demerouti EA; Manginas AN; Athanassopoulos GD; Karatasakis GT; Leontiadis ED; Pavlides GS
    Respir Care; 2013 Feb; 58(2):e1-5. PubMed ID: 22710078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelin antagonism in pulmonary arterial hypertension.
    Lee SH; Channick RN
    Semin Respir Crit Care Med; 2005 Aug; 26(4):402-8. PubMed ID: 16121317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
    Beghetti M; Galiè N
    J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
    Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.
    Saggar R; Shapiro SS; Ross DJ; Fishbein MC; Zisman DA; Lynch JP; Weigt SS; Ardehali A; Belperio JA; Saggar R
    J Heart Lung Transplant; 2009 Sep; 28(9):964-7. PubMed ID: 19716051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.
    Halank M; Kolditz M; Opitz C; Hoeffken G; Ewert R
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):54-9. PubMed ID: 16489527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
    Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
    Leibovitch L; Matok I; Paret G
    Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.